Abstract

ObjectiveFamilial glucocorticoid deficiency (FGD) is a rare autosomal recessive disease characterized by isolated glucocorticoid deficiency with preserved mineralocorticoid secretion. Mutations in the ACTH receptor (MC2R) account for approximately 25% of all FGD cases, but since these are usually missense mutations, a degree of receptor function is frequently retained. A recent report, however, suggested that disturbances in the renin–aldosterone axis were seen in some patients with potentially more severe MC2R mutations. Furthermore, MC2R knock out mice have overt aldosterone deficiency and hyperkalaemia despite preservation of a normal zona glomerulosa. We wished to determine whether a group of patients with severe nonsense mutations of the MC2R exhibited evidence of mineralocorticoid deficiency, thereby challenging the conventional diagnostic feature of FGD which might result in diagnostic misclassification.DesignClinical review of patients with nonsense MC2R mutations.PatientsBetween 1993 and 2008, 164 patients with FGD were screened for mutations in the MC2R. Totally 42 patients (34 families) were found to have mutations in the MC2R. Of these, 6 patients (4 families) were found to have homozygous nonsense or frameshift mutations.ResultsMild disturbances in the renin–angiotensin–aldosterone axis were noted in four out of six patients, ranging from slightly elevated plasma renin levels to low aldosterone levels, although frank mineralocorticoid deficiency or electrolyte disturbance were not found. No patient required fludrocortisone replacement.ConclusionSevere nonsense and frameshift MC2R mutations are not associated with clinically significant mineralocorticoid deficiency and are thus unlikely to require long-term mineralocorticoid replacement.

Highlights

  • Severe nonsense and frameshift MC2R mutations are not associated with clinically significant mineralocorticoid deficiency and are unlikely to require long-term mineralocorticoid replacement. (Received 5 November 2008; returned for revision 24 November 2008; revised 1 December 2008; accepted 2 December 2008)

  • Familial glucocorticoid deficiency (FGD) (OMIM: #202200), otherwise known as hereditary unresponsiveness to ACTH, is a rare autosomal recessive disease characterized by isolated glucocorticoid deficiency in the absence of mineralocorticoid deficiency

  • Inactivating mutations in the ACTH receptor/MC2R in patients with FGD were first described in 1993.2,3 Since many other mutations have been identified which account for approximately 25% of cases of FGD

Read more

Summary

Introduction

Familial glucocorticoid deficiency (FGD) (OMIM: #202200), otherwise known as hereditary unresponsiveness to ACTH, is a rare autosomal recessive disease characterized by isolated glucocorticoid deficiency in the absence of mineralocorticoid deficiency. Inactivating mutations in the ACTH receptor/MC2R in patients with FGD were first described in 1993.2,3 Since many other mutations have been identified which account for approximately 25% of cases of FGD Missense mutations have been shown to result in varying degrees of impaired ACTH signalling, most often by affecting trafficking of the receptor to the cell surface, and by disruption of ligand binding and loss of signal transduction.[4,5,6,7] In comparison, homozygous nonsense and frameshift mutations are extremely rare and only one such mutation has been reported.[8] The expected result of such mutations would be a significantly truncated protein severely disrupting MC2R function.[9] Assessment of one truncating mutation of this type, the 652insA

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call